Dave manages the investment function at Connecticut Innovations. He has extensive senior-level experience in operations and finance, including more than 10 years as Executive Vice President, Treasurer and CFO of CuraGen Corporation, a former CI portfolio company. Dave was also involved in negotiating strategic and business development alliances with several pharmaceutical and biotech companies, including Roche, Bayer and Amgen-Freemont (Abgenix).